Assessing Adherence to Antihypertensive Therapy in Primary Health Care in Namibia: Findings and Implications
Open accessAbstract
INTRODUCTION: Namibia has the highest burden and incidence of hypertension in sub-Sahara Africa. Though non-adherence to antihypertensive therapy is an important cardiovascular risk factor, little is known about potential ways to improve adherence in Namibia following universal access. The objective of this study is to validate the Hill-Bone compliance scale and determine the level and predictors of adherence to antihypertensive treatment in primary health care settings in sub-urban townships of Windhoek, Namibia. METHODS: Reliability was determined by Cronbach's alpha. Principal component analysis (PCA) was used to assess construct validity. RESULTS: The PCA was consistent with the three constructs for 12 items, explaining 24.1, 16.7 and 10.8% of the variance. Cronbach's alpha was 0.695. None of the 120 patients had perfect adherence to antihypertensive therapy, and less than half had acceptable levels of adherence (≥ 80%). The mean adherence level was 76.7 ± 8.1%. Three quarters of patients ever missed their scheduled clinic appointment. Having a family support system (OR = 5.4, 95% CI 1.687-27.6, p = 0.045) and attendance of follow-up visits (OR = 3.1, 95% CI 1.1-8.7, p = 0.03) were significant predictors of adherence. Having HIV/AIDs did not lower adherence. CONCLUSIONS: The modified Namibian version of the Hill-Bone scale is reliable and valid for assessing adherence to antihypertensives in Namibia. There is sub-optimal adherence to antihypertensive therapy among primary health cares in Namibia. This needs standardized systems to strengthen adherence monitoring as well as investigation of other factors including transport to take full advantage of universal access.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Patient adherence to hypertension treatment in other sub-Saharan African countries has been assessed through surveys, with adherence levels ranging from 17% in Kampala, Uganda to 61.8% in Ethiopia.
“These surveys have found levels of adherence ranging from 17% in a survey of 112 hypertensive patients in two city hospitals in Kampala, Uganda, to 61.8% of patients compliant with antihypertensive medications at Jimma University Specialised Hospital in Ethiopia.9,10”
From The outpatient management of hypertension at two Sierra Leonean health centres: A mixed-method investigation of follow-up compliance and patient-reported barriers to care (2020) · cites this paper as [11]
The Discussion compares adherence findings in Namibia with studies in other African countries, so the source supports the general point that adherence has been assessed elsewhere. It does not report the claimed 17% result from Kampala or 61.8% result from Jimma; searches for those figures and locations found no matching passage. Page numbers were not available in our copy. (LLM, conf=0.78)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Better compliance to antihypertensive medications reduces cardiovascular risk
Corrao, G., Parodi, A., Nicotra, F., Zambon, A., Merlino, L., Cesana, G., & Mancia, G. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328342ca97 · Cited by 367 · see citing works
Mugwano, I., Kaddumukasa, M., Mugenyi, L., Kayima, J., Ddumba, E., Sajatovic, M., Sila, C., DeGeorgia, M., & Katabira, E. (2016) · BMC Research Notes · doi:10.1186/s13104-015-1830-4 · Cited by 47 · see citing works
Flagged first, then by citations
Research works printed but not linked: 37
- [2]Ataklte F Erqou S Kaptoge S Taye B Echouffo-Tcheugui JB Kengne AP Burden of undiagnosed hypertension in Sub-Saharan Africa: a systematic review and meta-analysis Hypertension 2015 65 2 291 298 10.1161/HYPERTENSIONAHA.114.04394 25385758 · DOI · Paper page
- [3]Lawes CM Vander Hoorn S Rodgers A Global burden of blood-pressure-related disease, 2001 Lancet 2008 371 9623 1513 1518 10.1016/S0140-6736(08)60655-8 18456100 · DOI
- [4]Irazola VE Gutierrez L Bloomfield G Carrillo-Larco RM Dorairaj P Gaziano T Hypertension prevalence, awareness, treatment, and control in selected low and middle income countries (LMIC) communities: results from the NHLBI/UHG Network of Centers of Excellence for Chronic Diseases Glob Heart 2016 11 1 47 59 10.1016/j.gheart.2015.12.008 27102022 PMC4843831 · DOI
- [6]Nielsen JO Shrestha AD Neupane D Kallestrup P Non-adherence to anti-hypertensive medication in low- and middle-income countries: a systematic review and meta-analysis of 92443 subjects J Hum Hypertens 2017 31 1 14 21 10.1038/jhh.2016.31 27306087 · DOI
- [7]Hendriks ME Wit FWNM Roos MTL Brewster LM Akande TM de Beer IH Hypertension in Sub-Saharan Africa: cross-sectional surveys in four rural and urban communities PLoS One 2012 7 3 e32638 10.1371/journal.pone.0032638 22427857 PMC3299675 · DOI
- [8]Chobanian AV Bakris GL Black HR Cushman WC Green LA Izzo JL Jr Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure Hypertension 2003 42 6 1206 1252 10.1161/01.HYP.0000107251.49515.c2 14656957 · DOI · Paper page
- [13]Krousel-Wood M Thomas S Muntner P Morisky D Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients Curr Opin Cardiol 2004 19 4 357 362 10.1097/01.hco.0000126978.03828.9e 15218396 · DOI
- [14]Calhoun DA Jones D Textor S Goff DC Murphy TP Toto RD Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Hypertension 2008 51 6 1403 1419 10.1161/HYPERTENSIONAHA.108.189141 18391085 · DOI
- [15]Mant J McManus RJ Does it matter whether patients take their antihypertensive medication as prescribed? The complex relationship between adherence and blood pressure control J Hum Hypertens 2006 20 8 551 553 10.1038/sj.jhh.1002046 16710290 · DOI
- [18]Ministry of Health and Social Services. National medicines policy 2nd edition. Republic of Namibia Ministry of Health and Social Services, Windhoek, Namibia. 2011.
- [20]Cameron A Ewen M Ross-Degnan D Ball D Laing R Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis Lancet 2009 373 9659 240 249 10.1016/S0140-6736(08)61762-6 19042012 · DOI · Paper page
- [21]Bell R Ithindi T Low A Improving equity in the provision of primary health care: lessons from decentralized planning and management in Namibia Bull World Health Organ 2002 80 8 675 681 12219160 PMC2567583
- [22]Mweene D Banda J Andrews B M-Mweene M Lakhi S Factors associated with poor medication adherence in hypertensive patients in Lusaka, Zambia Med J Zambia 2010 37 3 252 261 PMC3866919 24363467
- [24]Kim MT Hill MN Bone LR Levine DM Development and testing of the hill-bone compliance to high blood pressure therapy scale Prog Cardiovasc Nurs 2000 15 3 90 96 10.1111/j.1751-7117.2000.tb00211.x 10951950 · DOI · Paper page
- [26]Dehghan M Nayeri ND Iranmanesh S Validating the Persian version of the Hill-Bone’s scale of “compliance to high blood pressure therapy” Br J Med Med Res 2015 5 2 235 246 10.9734/BJMMR/2015/13061 · DOI
- [27]Lambert EV Steyn K Stender S Everage N Fourie JM Hill M Cross-cultural validation of the hill-bone compliance to high blood pressure therapy scale in a South African, primary healthcare setting Ethn Dis 2006 16 286 291 16599385
- [28]Culig J Leppee M From Morisky to Hill-bone; self-reports scales for measuring adherence to medication Coll Antropol 2014 38 1 55 62 24851597
- [29]Berra E Azizi M Capron A Hoieggen A Rabbia F Kjeldsen SE Evaluation of adherence should become an integral part of assessment of patients with apparently treatment-resistant hypertension Hypertension 2016 68 2 297 306 10.1161/HYPERTENSIONAHA.116.07464 27296995 · DOI · Paper page
- [30]Inkster ME Donnan PT MacDonald TM Sullivan FM Fahey T Adherence to antihypertensive medication and association with patient and practice factors J Hum Hypertens 2006 20 4 295 297 10.1038/sj.jhh.1001981 16424861 · DOI
- [31]Karademir M Koseoglu IH Vatansever K Van Den Akker M Validity and reliability of the Turkish version of the Hill-Bone compliance to high blood pressure therapy scale for use in primary health care settings Eur J Gen Pract 2009 15 4 207 211 10.3109/13814780903452150 20055720 · DOI
- [32]Lavsa SM Holzworth A Ansani NT Selection of a validated scale for measuring medication adherence J Am Pharm Assoc 2011 51 1 90 94 10.1331/JAPhA.2011.09154 21247831 · DOI
- [33]Song Y Han HR Song HJ Nam S Nguyen T Kim MT Psychometric evaluation of hill-bone medication adherence subscale Asian Nurs Res 2011 5 3 183 188 10.1016/j.anr.2011.09.007 25030368 · DOI
- [34]Uchmanowicz I Jankowska-Polańska B Chudiak A Szymańska-Chabowska A Mazur G Psychometric evaluation of the polish adaptation of the hill-bone compliance to high blood pressure therapy scale BMC Cardiovasc Disord 2016 16 87 10.1186/s12872-016-0270-y 27165782 PMC4862115 · DOI
- [35]Mafutha GN Wright SC Compliance or non-compliance of hypertensive adults to hypertension management at three primary healthcare day clinics in Tshwane Curationis 2013 36 1 E1 E6 10.4102/curationis.v36i1.52 26697613 · DOI
- [37]Demoner MS Ramos ERDP Pereira ER Factors associated with adherence to antihypertensive treatment in a primary care unit Acta Paulista de Enfermagem 2012 25 Special Issue 1 27 34 10.1590/S0103-21002012000800005 · DOI
- [39]Jones JK Gorkin L Lian JF Staffa JA Fletcher AP Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population BMJ 1995 311 7000 293 295 10.1136/bmj.311.7000.293 7633238 PMC2550362 · DOI
- [40]Ma C A cross-sectional survey of medication adherence and associated factors for rural patients with hypertension Appl Nurs Res 2016 31 94 99 10.1016/j.apnr.2016.01.004 27397825 · DOI
- [41]Ambaw AD Alemie GA W/Yohannes SM Mengesha ZB Adherence to antihypertensive treatment and associated factors among patients on follow up at University of Gondar Hospital, Northwest Ethiopia BMC Public Health 2012 12 282 10.1186/1471-2458-12-282 22490130 PMC3395566 · DOI
- [42]Coleman R Gill G Wilkinson D Noncommunicable disease management in resource-poor settings: a primary care model from rural South Africa Bull World Health Organ 1998 76 6 633 640 10191559 PMC2312489
- [43]Erhun WO Agbani EO Bolaji EE Positive benefits of a pharmacist-managed hypertension clinic in Nigeria Public Health 2005 119 9 792 798 10.1016/j.puhe.2004.11.009 15990127 · DOI
- [44]Saounatsou M Patsi O Fasoi G Stylianou M Kavga A Economou O The influence of the hypertensive patient’s education in compliance with their medication Public Health Nurs 2001 18 6 436 442 10.1046/j.1525-1446.2001.00436.x 11737812 · DOI
- [45]Yiannakopoulou E Papadopulos JS Cokkinos DV Mountokalakis TD Adherence to antihypertensive treatment: a critical factor for blood pressure control Eur J Cardiovasc Prev Rehabil 2005 12 3 243 249 10.1097/00149831-200506000-00010 15942423 · DOI
- [47]Adams AS Uratsu C Dyer W Magid D O’Connor P Beck A Health system factors and antihypertensive adherence in a diverse cohort of new users JAMA Intern Med 2013 173 1 54 61 10.1001/2013.jamainternmed.955 23229831 PMC5105889 · DOI
- [48]Akeroyd JM Chan WJ Kamal AK Palaniappan L Virani SS Adherence to cardiovascular medications in the South Asian population: a systematic review of current evidence and future directions World J Cardiol 2015 7 12 938 947 10.4330/wjc.v7.i12.938 26730300 PMC4691821 · DOI
- [49]Harmon G Lefante J Krousel-Wood M Overcoming barriers: the role of providers in improving patient adherence to antihypertensive medications Curr Opin Cardiol 2006 21 4 310 315 10.1097/01.hco.0000231400.10104.e2 16755199 · DOI
- [50]Mancia G Fagard R Narkiewicz K Redon J Zanchetti A Bohm M 2013 European Society of Hypertension/European Society of Cardiology(ESH/ESC) guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension J Hypertens 2013 31 7 1281 1357 10.1097/01.hjh.0000431740.32696.cc 23817082 · DOI · Paper page
- [51]Rwegerera G, Moshomo T, Gaenamong M, Oyewo TA, Gollakota S, Mhimbira FA, et al. Antidiabetic medication adherence and associated factors among patients in Botswana; implications for the future. Alex J Med. 2017; 10.1016/j.ajme.2017.01.005. · DOI
Cited by
Sorted by citations
Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries
Godman, B., Egwuenu, A. J., Haque, M., Malande, O. O., Schellack, N., Kumar, S., Saleem, Z., Sneddon, J., Hoxha, I., Islam, S., et al. (2021) · Life · doi:10.3390/life11060528 · Cited by 238 · see citing works
Self-citationGodman, B., Haque, M., McKimm, J., Abu Bakar, M., Sneddon, J., Wale, J., Campbell, S., Martin, A. P., Hoxha, I., Abilova, V., et al. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1700947 · Cited by 171 · see citing works
Self-citationGodman, B., Bucsics, A., Bonanno, P. V., Oortwijn, W., Rothe, C. C., Ferrario, A., Bosselli, S., Hill, A., Martin, A., Simoens, S., et al. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00328 · Cited by 140 · see citing works
Self-citationGodman, B., Basu, D., Pillay, Y. G., Mwita, J. C., Rwegerera, G. M., Paramadhas, B. D. A., Tiroyakgosi, C., Okwen, P., Niba, L. L., Nonvignon, J., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00108 · Cited by 141 · see citing works
“Access to physicians and medicines continues to be a challenge especially if this involves high patient co-payments and/ or there are long distances and queues to see a healthcare professional, both of which have economic and emotional consequences for patients (Mendenhall and Norris, 2015; Dube et al., 2017; Nashilon…”
BackgroundSelf-citationGodman, B., McCabe, H., Leong, T., Mueller, D., Martin, A., Hoxha, I., Mwita, J., Rwegerera, G., Massele, A., Costa, J. D. O., et al. (2020) · Expert review of pharmacoeconomics & outcomes research · doi:10.1080/14737167.2020.1734456 · Cited by 87 · see citing works
Self-citationNiaz, Q., Godman, B., Massele, A., Campbell, S. M., Kurdi, A., Kagoya, H., & Kibuule, D. (2018) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzy172 · Cited by 82 · see citing works
“11 with cardiovascular disease given current high prevalence rates in Namibia and concerns with adherence [44], as well as HbA1c levels in patients with type 2 diabetes, similar to initiatives in the UK [45, 46].”
ResultSelf-citationSefah, I. A., Ogunleye, O. O., Essah, D. O., Opanga, S. A., Butt, N., Wamaitha, A., Guantai, A. N., Chikowe, I., Khuluza, F., Kibuule, D., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.588106 · Cited by 67 · see citing works
Self-citationNiaz, Q., Godman, B., Campbell, S., & Kibuule, D. (2020) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-020-01056-7 · Cited by 66 · see citing works
Self-citationGodman, B., Basu, D., Pillay, Y. G., Almeida, P. H. R. F., Mwita, J. C., Rwegerera, G. M., Paramadhas, B. D. A., Tiroyakgosi, C., Okwen, P., Niba, L. L., et al. (2020) · Hospital Practice · doi:10.1080/21548331.2020.1745509 · Cited by 52 · see citing works
Self-citationThe Effect of Social Support on Treatment Adherence in Hypertension in China
Pan, J., Hu, B., Wu, L., & Li, Y. (2021) · Patient Preference and Adherence · doi:10.2147/ppa.s325793 · Cited by 53 · see citing works
“Percent adherence was calculated using the formula %adherence = (Hill-bone score-14) ×100/42.(29) Fourteen is the minimum score, and 42 is the range of scores (56–14).”
MethodSefah, I., Essah, D., Kurdi, A., Sneddon, J., Alalbila, T., Kordorwu, H., & Godman, B. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab080 · Cited by 44 · see citing works
Self-citationGodman, B., Grobler, C., Van-De-Lisle, M., Wale, J., Barbosa, W. B., Massele, A. Y., Opondo, P. R., Petrova, G. I., Tachkov, K., Sefah, I. A., et al. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1684473 · Cited by 48 · see citing works
Self-citationKibuule, D., Nambahu, L., Sefah, I. A., Kurdi, A. B., Phuong, T. N. T., Kwon, H.-Y., & Godman, B. (2021) · Scholars Academic Journal of Pharmacy · doi:10.36347/sajp.2021.v10i05.001 · Cited by 41 · see citing works
“In addition, regulations banning the self-purchasing of antimicrobials [43-45].”
BackgroundSelf-citationBrathwaite, R., Hutchinson, E., McKee, M., Palafox, B., & Balabanova, D. (2020) · International Journal of Health Policy and Management · doi:10.34172/ijhpm.2020.105 · Cited by 31 · see citing works
Haines, H., Meyer, J., Summers, R., & Godman, B. (2019) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-020-02862-8 · Cited by 40 · see citing works
Self-citationMakhele, L., Matlala, M., Sibanda, M., Martin, A., & Godman, B. (2019) · PharmacoEconomics - Open · doi:10.1007/s41669-019-0124-5 · Cited by 39 · see citing works
Self-citationNyaaba, G., Masana, L., Aikins, A. D., Beune, E., & Agyemang, C. (2020) · Public Health · doi:10.1016/j.puhe.2019.11.007 · Cited by 37 · see citing works
Shakya, R., Shrestha, S., Gautam, R., Rai, L., Maharjan, S., Satyal, G. K., Bhuvan, K. C., & Rai, M. K. (2020) · Patient Preference and Adherence · doi:10.2147/ppa.s270786 · Cited by 35 · see citing works
Kamati, M., Godman, B., & Kibuule, D. (2019) · Journal of Research in Pharmacy Practice · doi:10.4103/jrpp.jrpp_19_121 · Cited by 32 · see citing works
Self-citationRampamba, E. M., Meyer, J. C., Godman, B., Kurdi, A. B., & Helberg, E. A. (2018) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2018-0004 · Cited by 34 · see citing works
Self-citationAli, M. H., Alrasheedy, A., Kibuule, D., Godman, B., Hassali, M., & Ali, H. M. H. (2019) · Expert Review of Anti-Infective Therapy · doi:10.1080/14787210.2019.1689818 · Cited by 28
Self-citationAdherence to Antihypertensive Therapy and Its Determinants: A Systematic Review
Ferreira, P. D., Simões, J. A., & Velho, D. C. (2024) · Cureus · doi:10.7759/cureus.59532 · Cited by 25 · see citing works
Sarfo, F., Norman, B., Nichols, M., Appiah, L., Assibey, S. O., Tagge, R., & Ovbiagele, B. (2020) · HIV Medicine · doi:10.1111/hiv.13007 · Cited by 24 · see citing works
Frequency and predictors of compliance among patients taking antihypertensive medicines
Mutneja, E., Yadav, R. K., Dey, A. B., & Gupta, P. (2020) · Indian Heart Journal · doi:10.1016/j.ihj.2020.03.008 · Cited by 24 · see citing works
Statin use in Brazil: findings and implications
do Nascimento, R. C. R. M., Guerra, A. A., Jr., Álvares-Teodoro, J., Gomes, I. C., Godman, B., Bennie, M., Kurdi, A. B., & Acúrcio, F. D. A. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1451312 · Cited by 26 · see citing works
“The objective is to prevent and control NCDs in view of their growing burden5, which is in line with the Sustainable Development Goal for NCDs proposed by the World Health Organization (WHO)1,6.”
BackgroundInfluentialSelf-citationCost-related nonadherence for prescription medications: a cross-sectional study in Jordan
Naser, A. Y. (2021) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2021.1899814 · Cited by 13 · see citing works
Alsofyani, M., Aloufi, A. O., Al-Qhtani, N. S., Bamansour, S. O., & Almathkori, R. S. (2022) · Journal of Family and Community Medicine · doi:10.4103/jfcm.jfcm_153_22 · Cited by 20 · see citing works
“[22] According to Nashilongo et al., 2017, most patients reported obtaining enough information on how to take their medicine from their healthcare providers; however, more than half of the patients were unaware of the effects of HTN and nonadherence to medication.”
BackgroundNakwafila, O., Mashamba-Thompson, T. P., Godi, A., & Sartorius, B. K. D. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19074416 · Cited by 18 · see citing works
“This could also have been the reason as to why our findings are different from those of a study conducted by Nashilongo et al. (2017) in Namibia in peri-urban settings in the same region (adherence = 48”
ResultXiong, S., Peoples, N., Østbye, T., Olsen, M. H., Zhong, X., Wainaina, C., Fan, S., Wambui, D. W., & Yan, L. L. (2022) · Journal of Human Hypertension · doi:10.1038/s41371-022-00656-2 · Cited by 25 · see citing works
Mwita, J., Francis, J., Omech, B., Botsile, E., Oyewo, A., Mokgwathi, M., Molefe-Baikai, O. J., Godman, B., & Tshikuka, J. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-026807 · Cited by 18 · see citing works
Self-citationKhan, T., Hussain, S., Ikram, A., Mahmood, S., Riaz, H., Jamil, A., Amin, A., Haider, Y. G., Sandhu, M., Mushtaq, A., et al. (2020) · Hospital Practice · doi:10.1080/21548331.2020.1762366 · Cited by 16 · see citing works
Self-citationAminde, L. N., Agbor, V. N., Fongwen, N. T., Ngwasiri, C. A., Nkoké, C., Nji, M., Dzudié, A., & Schutte, A. E. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.037555 · Cited by 20 · see citing works
“74,96 Social support: All but 1 74 of 4 studies 35,44,74,78 noted that having good family/friend support was associated with good medication adherence, with odds ratios (ORs) ranging from 2 35 to over 5-fold.”
Integrating hypertension and HIV care in Namibia: A quality improvement collaborative approach
Basenero, A., Neidel, J., Ikeda, D. J., Ashivudhi, H., Mpariwa, S., Kamangu, J., Kakubu, M. A. M., Hans, L., Mutandi, G., Jed, S. L., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272727 · Cited by 16 · see citing works
Conceptual Framework of the Impact of Health Technology on Healthcare System
Farid, S. F. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00933 · Cited by 22 · see citing works
Herskind, J., Zelasko, J., Bacher, K., & Holmes, D. (2020) · African Journal of Primary Health Care & Family Medicine · doi:10.4102/phcfm.v12i1.2222 · Cited by 15 · see citing works
Rwegerera, G. M., Molefe‐Baikai, O. J., Masaka, A., Shimwela, M., Rivera, Y. P., Oyewo, T. A., Godman, B., Massele, A. Y., & Habte, D. (2018) · Hospital Practice · doi:10.1080/21548331.2018.1506674 · Cited by 14 · see citing works
Self-citationPallangyo, P., Komba, M., Mkojera, Z., Kisenge, P. R., Bhalia, S. V., Mayala, H. A., Kifai, E., Richard, M. K., Khanbhai, K., Wibonela, S., et al. (2022) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s374674 · Cited by 22 · see citing works
Fadare, J., Enwere, O., Adeoti, A., Desalu, O., & Godman, B. (2020) · Value in Health Regional Issues · doi:10.1016/j.vhri.2020.05.005 · Cited by 14
Self-citationMoosa, A., Bezuidenhout, S., Meyer, J., & Godman, B. (2019) · Journal of Pharmaceutical Health Services Research · doi:10.1111/jphs.12283 · Cited by 14 · see citing works
Self-citationMapping inequalities in health service coverage in Africa: a scoping review
Karamagi, H., Afriyie, D. O., Charif, A. B., Sy, S., Kipruto, H., Moyo, T., Oyelade, T. A., & Droti, B. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-082918 · Cited by 12 · see citing works
A Systematic Review of the Hill-Bone Compliance to Blood Pressure Therapy Scale
Commodore-Mensah, Y., Delva, S., Ogungbe, O., Smulcer, L., Rives, S., Himmelfarb, C. D. D., Kim, M. T., Lee, B.-N. R., Levine, D. M., & Hill, M. (2023) · Patient Preference and Adherence · doi:10.2147/ppa.s412198 · Cited by 12 · see citing works
Shakya, R., Shrestha, R., Shrestha, S., Sapkota, P., Gautam, R., Rai, L., Khatiwada, A., Ranabhat, K., Kc, B., Sapkota, B., et al. (2022) · Patient Preference and Adherence · doi:10.2147/ppa.s349760 · Cited by 11 · see citing works
Sharma, J. R., Dludla, P. V., Dwivedi, G., & Johnson, R. (2023) · Global Heart · doi:10.5334/gh.1191 · Cited by 10 · see citing works
Poverty and Cardiovascular Diseases in Sub-Saharan Africa
Mwita, J. C., & Godman, B. (2021) · Lifestyle and Epidemiology - Poverty and Cardiovascular Diseases a Double Burden in African Populations [Working Title] · doi:10.5772/intechopen.98575 · Cited by 10 · see citing works
Self-citationSarfo, F., Norman, B., Appiah, L., & Ovbiagele, B. (2021) · The Journal of Clinical Hypertension · doi:10.1111/jch.14255 · Cited by 10 · see citing works
Harsha, N., Kőrösi, L., Pálinkás, A., Bíró, K., Boruzs, K., Ádány, R., Sándor, J., & Czifra, Á. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01280 · Cited by 13 · see citing works
“Those factors include patients’ demographic (age and sex) and socioeconomic status (e.g., education, income, and social support) (Krousel-Wood et al., 2004; Park et al., 2008; Peek et al., 2016; Boruzs et al., 2016; Nashilongo et al., 2017).”
BackgroundNakwafila, O., Sartorius, B. K. D., Shumba, T. W., Dzinamarira, T., & Mashamba-Thompson, T. P. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-068238 · Cited by 8 · see citing works
Rusu, R.-N., Gavril, R. S., Ababei, D. C., Macadan, I., Ciobîcă, A., Nicolae, C., Popescu, R. I., Bild, W., & Bild, V. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1256848 · Cited by 9 · see citing works
Adeola, J., Odukoya, O. O., Igwilo, U. U., Usinoma, A., Bahiru, E. M., May, F. P., & Obiezu, F. (2023) · Annals of Global Health · doi:10.5334/aogh.4131 · Cited by 6 · see citing works
The Effect Of Counseling On The Adherence Of Therapeutic Hypertension Patients
Prihanti, G. S., Sari, N. P., Septiani, N., Tobing, L. P. R. L., Adrian, A. R., Ayu, N. R., Abidin, M. Z., & Farid, H. P. (2020) · Jurnal Keperawatan · doi:10.22219/jk.v11i2.11943 · Cited by 12 · see citing works
Rampamba, E., Meyer, J., Helberg, E., & Godman, B. (2020) · Journal of Research in Pharmacy Practice · doi:10.4103/jrpp.jrpp_20_49 · Cited by 6 · see citing works
“182 Journal of Research in Pharmacy Practice ¦ Volume 9 ¦ Issue 4 ¦ October-December 2020 help.[2,3,5,6] Previous surveys among 40 LMICs found the mean availability of chronic medicines was 14.”
BackgroundSelf-citationGarcia, M. M., Azevedo, P. S., Mirelman, A. J., Safatle, L. P., Iunes, R. F., Bennie, M., Godman, B., & Guerra, A. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00370 · Cited by 7 · see citing works
“…and sub-Saharan Africa where care for patients in the public healthcare system is provided via primary healthcare centers or outpatient clinics which can cover the cost of medicines supplied (Rezal et al., 2015; Meyer et al., 2017; Nashilongo et al., 2017; Mbui et al., 2017; Mashalla et al., 2017).”
BackgroundSelf-citationSheikh, A., Rwegerera, G., Godman, B., & Habte, D. (2019) · Hospital Practice · doi:10.1080/21548331.2019.1685800 · Cited by 6
Self-citationNão adesão ao tratamento medicamentoso da hipertensão arterial sistêmica na atenção básica de saúde
de Albuquerque, K. R., Borges, J., & Rodrigues, M. (2024) · Cadernos Saúde Coletiva · doi:10.1590/1414-462x202432010393 · Cited by 6
Mashozhera, S., Bamitale, S. K., Godman, B., & Kibuule, D. (2021) · Journal of Pharmaceutical Health Services Research · doi:10.1093/jphsr/rmaa017 · Cited by 5 · see citing works
Self-citationAl-Alaili, M. K., Abdi, A., & Başgut, B. (2022) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13805 · Cited by 4 · see citing works
Kudzinesta, M., Mubita, M., Kalemeera, F., Godman, B., Hango, E., & Kibuule, D. (2020) · Medicine Access @ Point of Care · doi:10.1177/2399202620910031 · Cited by 4
Self-citationOgunleye, O., Fadare, J., Eriksen, J., Oaiya, O., Massele, A., Truter, I., Taylor, S. J. E., Godman, B., & Gustafsson, L. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1605903 · Cited by 4
Self-citationAgasha, D. B., Edwin, B. M. R., & Baine, S. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00071 · Cited by 4
Wulandari, N., Hanifa, R. S., Balafas, S. E., Syaripuddin, M., Azam, M., Supardi, S., van der Schans, J., Feenstra, T., & Taxis, K. (2025) · Tropical Medicine & International Health · doi:10.1111/tmi.70076 · Cited by 1 · see citing works
To, H. M. H., Palafox, B., Balabanova, D., Palileo-Villanueva, L., & Mckee, M. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0004550 · Cited by 2 · see citing works
“[46 ] Similarly, research in Ghana revealed that sustaining livelihoods led to the de-prioritization of medical treatment.”
Moyo, E., Barham, L., Mhango, M., Musuka, G., & Dzinamarira, T. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.09.003 · Cited by 2
Srivastava, M., Srivastava, P. K., Kumar, D., & Kumar, A. (2026) · Environmental Earth Sciences · doi:10.1007/s12665-025-12721-3 · Cited by 1
Ipingbemi, A., Adisa, R., & Erhun, W. (2025) · Discover Health Systems · doi:10.1007/s44250-025-00337-0 · Cited by 1 · see citing works
“Although studies in low-and middle-income countries (LMICs), including Nigeria, have reported associations between medication adherence and blood pressure control [19, 20], few have examined adherence to dietary recommendations and physical activity [21, 22].”
Yirba, T. Y., Gebremariam, G., Tadesse, T., Degu, A., Mekonnen, D., & Alemkere, G. (2023) · Patient Preference and Adherence · doi:10.2147/ppa.s439715 · Cited by 1 · see citing works
Hango, E., Amakali, K., Shilunga, A., Kibuule, D., Godman, B., & Kalemeera, F. (2021) · Expert review of pharmacoeconomics & outcomes research · doi:10.1080/14737167.2022.2000863 · Cited by 1 · see citing works
Self-citationNakwafila, O., Sartorius, B., Nkambule, S., & Thompson, T. (2021) · Social Science Research Network · doi:10.2139/ssrn.3900409 · Cited by 1 · see citing works
Find and Plug the Leak: Improving Adherence to Anti-Hypertensive Medicines
Njuguna, B., & Vedanthan, R. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-017-6753-y · Cited by 1 · see citing works
“assessed the levels and predictors of adherence to antihypertensive medication, and validated a modified version of the Hill-Bone scale for compliance [9].”
MethodSiregar, F., Asfriyati, & Makmur, T. (2023) · E3S Web of Conferences · doi:10.1051/e3sconf/202344805023 · Cited by 1
Factors associated with medication adherence among hypertensive patients in Namibia
Ashipala, D., Joel, M. H., Nghikevali, A. V., & Victorinu, A. (2026) · Health SA = SA Gesondheid · doi:10.4102/hsag.v31i0.3178
“Namibian primary healthcare facilities are strategically located among underprivileged communities and have a critical role in providing hypertensive Namibians with access to care (Nashilongo et al. 2017).”
Şahi̇n, A., Di̇rgar, E., & Çicihan, D. (2025) · Global Nursing Insights · doi:10.31125/globnursinsights.1687643
Mateo, H. J. G., & Espaillat, J. F. (2025) · La Barca de Teseo · doi:10.61780/bdet.v3i1.50
Sales, I., & Alruthia, Y. (2024) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2024.102053
“…differences, the scale was determined to be suitable for our population in this study (Dennison, Peer et al., 2007, Karademir, Koseoglu et al., 2009, Koschack, Marx et al., 2010, Song, Han et al., 2011, Alsolami, Hou et al., 2013, Cheong, Tong et al., 2015, Nashilongo, Singu et al., 2017).”
MethodChaudhary, A. P., George, J., Kadowade, K., Faiyza, L., Anjum, R., M, U., & N, S. (2021) · International Journal of Pharmaceutical Investigation · doi:10.5530/ijpi.2021.4.76
Popović, M. (2023) · Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma · doi:10.5937/mgiszm2390007p
Vafaei, A., Ghorbani, R., Zarvani, P., & Nobahar, M. (2026) · Vascular Health and Risk Management · doi:10.2147/vhrm.s646427
- Authors
- Nashilongo, M. M., Singu, B., Kalemeera, F., Mubita, M., Naikaku, E., Baker, A., Ferrario, A., Godman, B., Achieng, L., & Kibuule, D.
- Affiliations
- University of Namibia (NA)
- London School of Economics and Political Science (GB)
- Karolinska University Hospital (SE)
- University of Nairobi (KE)
- Corresponding author
- Godman, B.
- Venue
- Cardiovascular Drugs and Therapy
- Published
- 2017-10-14
- Volume
- 31
- Issue
- 5-6
- Pages
- 565-578
- ISSN
- 0920-3206 (ISSN-L)
- 1573-7241
- PMC
- PMC5730630
- OpenAlex
- W2743658562
- Cited by
- 87
- References
- 46
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 5 · 2023: 10 · 2022: 8 · 2021: 16 · 2020: 19 · 2019: 13 · 2018: 5 · 2017: 2
- FWCI
- 11.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Cardiovascular Drugs and Therapy (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- London School of Economics and Political Science Research Online (London School of Economics and Political Science) (acceptedVersion)
- London School of Economics and Political Science Research Online (London School of Economics and Political Science) (submittedVersion, cc-by)
- Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) (submittedVersion, cc-by)
- Greater South Information System
- Funders
- Karolinska Institute
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacy and Medical Practices
- Keywords
- antihypertensive medication adherence, hypertension, scale validation, predictors of adherence, family support, follow-up visits, missed appointments, HIV/AIDS, universal health coverage, primary care
- MeSH terms
- Assessment of Medication Adherence, Antihypertensive Agents, Cross-Sectional Studies, Humans, Hypertension, Namibia, Primary Health Care, Drug Monitoring, Principal Component Analysis, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review